BU-NOT-SET

CONTACT US
Ensuring stability excellence for global consumer and OTC products
  • Analytical chemistry
  • Drug product
Woman and computer
Webinar
The impact of the COVID-19 pandemic on global pharmaceutical growth
  • Industry trends
Eyes
Insight
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Time and cost-effective solubility improvement
  • Drug substance
Eyes
Insight
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field